Yeah, and when the next round of studies are released, and all the animals survive Ebola, Marburg and Dengue, it will also be "business as usual." The only thing that won't be "business as usual" will be if the EKC infected rabbits have their sight restored. Even then, the results may be received the same as many will say, "So, what did you expect? It's a broad spectrum antiviral." *Yawn* LOL